In this issue:
Clofarabine +/- ARA-C in old-age AML
FCR as initial therapy in CLL: long-term results
Dasatinib in CNS Ph+leukaemia
Lenalidomide + rituximab: cytotoxicity in CLL cells
CBCL: EORTC and ISCL recommendations
PTCL and NKTCL: pathology & outcomes
Statins impair antitumour effects of rituximab
Bendamustine + rituximab in NHL & mantle cell lymphoma
CODOX-M/IVAC in BL
PHL/PSL: prognosis & HCV infection
Please login below to download this issue (PDF)